Wednesday, February 18, 2026
  • Login
Euro Times
No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
Euro Times
No Result
View All Result

Walgreens, Coinbase, Duolingo, Ralph Lauren

by Euro Times
November 12, 2022
in Stock Market
Reading Time: 4 mins read
A A
0
Home Stock Market
Share on FacebookShare on Twitter


A Walgreens store is seen on August 07, 2019 in Miami, Florida.

Joe Raedle | Getty Images

Check out the companies making headlines in midday trading.

Doximity — The online platform for medical professionals skyrocketed more than 32.7% after the company reported better-than-expected quarterly results. Doximity also announced a new share repurchase program.

related investing news

CNBC Pro
JPMorgan double-downgrades Intel as chipmaker loses market share to rivals such as AMD

Walgreens — Shares rose 7.2% after an upgrade to buy from hold Deutsche Bank, which said it liked Walgreens’ merger and acquisition plans.

Coinbase — Coinbase jumped 12.8% after Piper Sandler reiterated its overweight rating on the stock, calling it well positioned to “weather a prolonged crypto winter.” The crypto industry is preparing for a major setback that’s likely to put more pressure on prices and suppress trading activity, after the sudden collapse of the popular FTX exchange.

Duolingo — Shares of the foreign language learning platform lost 13.4% after the company reported revenue below expectations while also posting a smaller-than-expected quarterly loss. Duolingo also bumped its full-year outlook.

Wynn Resorts — The casino stock jumped more than 8.3% after China said it would ease some Covid restrictions, trimming quarantine time for international travelers by two days. Wynn Resort’s operations in Macau came under pressure this year because of China’s strict Covid policies.

Ralph Lauren — The clothing maker popped 9.4% after it reported better-than-expected second-quarter earnings. UBS called the company a “turnaround stock,” noting useful changes to its business model.

GSK — Shares of the pharmaceutical company dropped 5.6% after GSK said Friday it would not use of an ovarian cancer drug in the United States for certain patients with consumer mutations, according to Reuters. It also got downgraded to neutral by UBS because of its “unattractive earnings scenario.”

Health stocks — Health care shares led the S&P 500 lower as investors rotated out of these steady outperformers this week in favor of growth stocks now that the market is rebounding. Among the laggards were Cigna (down 6%), Elevance (5.9% lower), Humana (slipping 5.3%), Vertex (dipping 2.5%) and Mckesson (down 3.8%).

Imax — Shares of the entertainment company traded up 6.9% after Wedbush named Imax one of its best ideas. The firm said the company was well-positioned to play the rebound in demand for theaters.

Netflix — The streaming giant rose 5.5% after JPMorgan reiterated the stock as overweight, citing “increased conviction” in the company’s ability to increase revenue growth, free cash flow and operating margins.

General Motors — The automotive giant’s stock jumped 3.5% after Citi reiterated the company as a top pick. Citi said it sees “growth and resilience” heading into the company’s investor day next week.

Amazon — Shares of Amazon rose 4.3% on a Wall Street Journal report that the company is review cost-cutting measures, particularly at unprofitable business units such as Alexa. Wall Street analysts at Bank of America and Morgan Stanley cheered the move.

LegalZoom — The stock added 10.4% following reporting a quarterly loss that was smaller than expected. The legal document provider also increased its full-year outlook.

Beazer Homes — Shares of the home construction company added 3.6% after Beazer beat expectations for earnings and revenue, noting it saw boosts from better home prices and profit margins.

— CNBC’s Yun Li, Tanaya Macheel, Sarah Min and Carmen Reinicke contributed reporting.



Source link

Tags: CoinbaseDuolingoLaurenRalphWalgreens
Previous Post

FTX crash pushes Bitcoin to self-custody; Ethereum switched for stablecoins

Next Post

Vasta Platform Limited 2022 Q3 – Results – Earnings Call Presentation (NASDAQ:VSTA)

Related Posts

General Mills: Flat-Sales Bias Masks An Overvalued Stock (NYSE:GIS)

General Mills: Flat-Sales Bias Masks An Overvalued Stock (NYSE:GIS)

by Brendan O'Boyle
February 18, 2026
0

This text was written byObserveBrendan, a Pennsylvanian by start:-Accomplished a Ph.D. at Stanford College within the discipline of natural synthesis...

South32 Limited (SOUHY) Q2 2026 Earnings Call Transcript

South32 Limited (SOUHY) Q2 2026 Earnings Call Transcript

by SA Transcripts
February 17, 2026
0

Graham KerrCEO, MD & Govt Director Good morning, everybody, and thanks for becoming a member of us at present. On...

Calamos International Growth Fund Q4 2025 Commentary (CIGIX)

Calamos International Growth Fund Q4 2025 Commentary (CIGIX)

by Calamos Investments
February 17, 2026
0

Calamos Investments is a diversified world funding agency providing revolutionary funding methods together with U.S. progress fairness, world fairness, convertible,...

PCCW Limited (PCCWY) Q4 2025 Earnings Call Prepared Remarks Transcript

PCCW Limited (PCCWY) Q4 2025 Earnings Call Prepared Remarks Transcript

by SA Transcripts
February 16, 2026
0

Operator Women and gents, welcome to the PCCW 2025 Annual Outcomes Announcement. Presenting at present are Ms. Susanna Hui, Appearing...

Columbia Threadneedle Fixed Income Monitor: February 2026

Columbia Threadneedle Fixed Income Monitor: February 2026

by Columbia Threadneedle Investments
February 13, 2026
0

Columbia Threadneedle Investments is a number one world asset administration group that gives a broad vary of actively managed funding...

CareDx, Inc. (CDNA) Discusses AlloHeme Clinical Validation Data Review and Launch Timeline in AML and MDS Post-Cell Therapy Transcript

CareDx, Inc. (CDNA) Discusses AlloHeme Clinical Validation Data Review and Launch Timeline in AML and MDS Post-Cell Therapy Transcript

by SA Transcripts
February 12, 2026
0

Operator Hiya, and thanks for standing by. Presently, I want to welcome everybody to the CareDx Investor Webinar Name. I...

Next Post
Vasta Platform Limited 2022 Q3 – Results – Earnings Call Presentation (NASDAQ:VSTA)

Vasta Platform Limited 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:VSTA)

Academics’ Strike Puts Spotlight on Nigeria’s Brain Drain — Global Issues

Academics' Strike Puts Spotlight on Nigeria's Brain Drain — Global Issues

*HOT* Room Essentials Mini Stick Table Lamp only , plus more!

*HOT* Room Essentials Mini Stick Table Lamp only $4, plus more!

February 18, 2026
Why your EV’s battery will outlive your phone’s battery – and by how much

Why your EV’s battery will outlive your phone’s battery – and by how much

February 18, 2026
8 skiers found dead, 1 still missing in deadliest avalanche in Northern California in decades

8 skiers found dead, 1 still missing in deadliest avalanche in Northern California in decades

February 18, 2026
General Mills: Flat-Sales Bias Masks An Overvalued Stock (NYSE:GIS)

General Mills: Flat-Sales Bias Masks An Overvalued Stock (NYSE:GIS)

February 18, 2026
10 High Dividend Stocks With Low Volatility

10 High Dividend Stocks With Low Volatility

February 18, 2026
‘Worst paper I’ve ever seen’

‘Worst paper I’ve ever seen’

February 18, 2026
Euro Times

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Finance
  • Health
  • Investing
  • Markets
  • Politics
  • Stock Market
  • Technology
  • Uncategorized
  • World

LATEST UPDATES

*HOT* Room Essentials Mini Stick Table Lamp only $4, plus more!

Why your EV’s battery will outlive your phone’s battery – and by how much

  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In